Loading tape…Loading tape…
ILMN
ILMN
ILMN
ILMN NASDAQ
Illumina Inc is highlighted in recent market coverage asking 'Should You Add Illumina Stock to Your Portfolio Now?'. The company currently holds a market capitalization of approximately $33.02 billion and generated $4.34 billion in FY revenue. With a diluted TTM EPS of roughly 5.46, Illumina trades at a PE ratio of 40.34 and exhibits a free cash flow yield of 2.84%.
Based on zacks.comShould You Add Illumina Stock to Your Portfolio Now?
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here's Who's Best Positioned.
Biondo Investment Advisors LLC Takes $1.87 Million Position in Illumina, Inc. $ILMN
Allworth Financial LP Purchases New Position in Illumina, Inc. $ILMN
Illumina, Inc. Post Earnings: Buy On A Pullback
BMRN vs. ILMN: Which Stock Is the Better Value Option?
Revenue & Net Income (5Y)
EPS & Growth (5Y)
Free Cash Flow (5Y)
Capital Returns
Operating & Net Margin (5Y)
CapEx vs. Free Cash Flow (5Y)
Capital Allocation (5Y)
R&D and SG&A Intensity (5Y)
EBITDA (5Y)
Cost of Revenue (5Y)
Market Cap (5Y)
Ask Stonks with professional market data, charts beside chat, and your portfolio context.
Tape shows delayed public market data. Not investment advice.